Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Go to Funding Search

Key Information

Due Date: November 5, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Grant


Match Required: No


Contact Info: OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

This is a grant titled, "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)". It encourages research related to creating new methods of screening or therapeutic treatments for severe or potentially fatal conditions discovered through newborn screening. This includes "high priority" genetic conditions that are not currently recommended for screening but may be in the near future.

Such "high priority" conditions are those where early detection and treatment could significantly benefit the child. The aim of this grant is to develop an accurate screening test and demonstrate the advantages of prompt intervention or treatment. These are crucial prerequisites to include a condition in a newborn screening panel. The ultimate goal of this grant is to improve the early detection and treatment of serious conditions in newborns.

Show More

Key Dates

Open Date: November 9, 2021


Application Due Date: November 5, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.